Astera Labs (NASDAQ:ALAB) Stock Price Down 7.9% – Here’s What Happened

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 7.9% on Tuesday . The company traded as low as $251.17 and last traded at $260.23. Approximately 4,710,154 shares were traded during mid-day trading, a decline of 15% from the average daily volume of 5,533,342 shares. The stock had previously closed at $282.52.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada upped their target price on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. Barclays raised their price target on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Morgan Stanley increased their price objective on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $282.00.

Astera Labs Stock Down 7.9%

The company’s fifty day moving average is $360.28 and its two-hundred day moving average is $226.92. The stock has a market cap of $44.61 billion, a price-to-earnings ratio of 175.83, a PEG ratio of 3.38 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the business posted $0.33 EPS. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Bethany Mayer sold 686 shares of the firm’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the sale, the director directly owned 5,550 shares in the company, valued at $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Reflection Asset Management acquired a new stake in shares of Astera Labs during the 4th quarter worth about $25,000. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs in the fourth quarter valued at approximately $33,000. Whipplewood Advisors LLC increased its stake in Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the last quarter. Finally, Assetmark Inc. increased its stake in Astera Labs by 78.9% in the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.